Skip to main content

Table 4 Patient Distribution Between the Model Health States at Baseline

From: Economic modeling of the combined effects of HIV-disease, cholesterol and lipoatrophy based on ACTG 5142 trial data

Base Health State

CD4 Range

VL Range

EFV Percent

LPV/r Percent

Difference %*

2

>500

>400

6.4

2.8

3.6

4

350-499

>400

14.8

11.4

3.4

6

200-349

400-10,000

8.8

8.7

0.1

7

200-349

>10,000

18.8

23.2

-4.4

9

50-199

400-10,000

3.6

2.4

1.2

10

50-199

10,001-100,000

10.0

16.9

-6.9

11

50-199

>100,000

11.2

15.4

-4.2

12

<50

any

26.4

19.3

7.1

  1. *Chi-Square 15.5; p = 0.0301